e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Contraindications and precautions with inhalation therapy in COPD. Awareness or unawareness, a questionaire
C. N. Meyer (Roskilde, Denmark)
Source:
Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Session:
Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Session type:
Thematic Poster Session
Number:
698
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. N. Meyer (Roskilde, Denmark). Contraindications and precautions with inhalation therapy in COPD. Awareness or unawareness, a questionaire. Eur Respir J 2013; 42: Suppl. 57, 698
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014
The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes
Source: International Congress 2014 – Markers
Year: 2014
Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Hospital treatment costs of exacerbations in COPD patients with indications for LTOT
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
The influence of type of inhalation device on adherence of COPD patients to inhaled medication
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Assessing COPD profiles and outcomes by dyspnoea severity
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Patients’ opinion for their inhalation device. An assessment of convenience and use
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Safety of tiotropium in patients with cardiac events in the TIOSPIR™ trial
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015
Clinical and inhaled drug profile of COPD patients with indication for beta-blockers who are on beta-blockers
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Differences in adherence to common inhaled medications in COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Inhaled treatment of COPD: A delphi consensus statement
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Use of beta-blockers in COPD patients with heart-disease. BBEPOC study
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Predictors of good inhaler technique in asthma and COPD
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Changes in inhalation therapy after combined assessment of COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept